Park Ha Biological Technology (BYAH) Invested Capital (2023 - 2026)

Park Ha Biological Technology has reported Invested Capital for 4 years, with the latest figure at $2.0 million in Q2 2026.

• On a quarterly basis, Invested Capital fell 54.45% year-over-year to $2.0 million in Q2 2026; TTM through Apr 2026 was $2.0 million, a 54.45% decrease from a year earlier, with the FY2025 full-year figure at $884395.0, down 70.72% from the prior year.
• Invested Capital was $2.0 million for Q2 2026 at Park Ha Biological Technology, up from $884395.0 in the prior quarter.
• The five-year high for Invested Capital was $4.3 million in Q2 2025, with the low at $884395.0 in Q4 2025.
• Average Invested Capital over 4 years is $2.2 million, with a median of $2.0 million recorded in 2026.
• The sharpest annual moves came in 2024 and 2025: Invested Capital soared 195.57% in 2024, then tumbled 70.72% in 2025.
• Over 4 years, Invested Capital stood at $1.0 million in 2023, then jumped by 195.57% to $3.0 million in 2024, then tumbled by 70.72% to $884395.0 in 2025, then surged by 122.16% to $2.0 million in 2026.
• The last three Invested Capital figures came in at $2.0 million (Q2 2026), $884395.0 (Q4 2025), and $4.3 million (Q2 2025), per Business Quant data.